NMGCX | PMAQX | NMGCX / PMAQX | |
Total Expense Ratio | 1.81 | 0.59 | 307% |
Annual Report Gross Expense Ratio | 1.81 | 0.59 | 307% |
Fund Existence | 16 years | 9 years | - |
Gain YTD | 4.465 | 2.039 | 219% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.92B | 30.6B | 6% |
Annual Yield % from dividends | 0.00 | 0.19 | - |
Returns for 1 year | 5.82 | 10.62 | 55% |
Returns for 3 years | 30.18 | 50.92 | 59% |
Returns for 5 years | 5.63 | 56.82 | 10% |
Returns for 10 years | 10.26 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDNI | 33.29 | N/A | N/A |
First Trust Dow Jones Intl Intnt ETF | |||
IGSB | 52.31 | -0.07 | -0.13% |
iShares 1-5 Year invmt Grd Corp Bd ETF | |||
GTIP | 48.86 | -0.08 | -0.17% |
Goldman Sachs Acs Infl Protd USD Bd ETF | |||
HQL | 12.85 | -0.13 | -1.00% |
abrdn Life Sciences Investors | |||
IAI | 154.06 | -2.25 | -1.44% |
iShares US Broker-Dealers&Secs Exchs ETF |